371 related articles for article (PubMed ID: 30308161)
1. Compositional and Temporal Changes in the Gut Microbiome of Pediatric Ulcerative Colitis Patients Are Linked to Disease Course.
Schirmer M; Denson L; Vlamakis H; Franzosa EA; Thomas S; Gotman NM; Rufo P; Baker SS; Sauer C; Markowitz J; Pfefferkorn M; Oliva-Hemker M; Rosh J; Otley A; Boyle B; Mack D; Baldassano R; Keljo D; LeLeiko N; Heyman M; Griffiths A; Patel AS; Noe J; Kugathasan S; Walters T; Huttenhower C; Hyams J; Xavier RJ
Cell Host Microbe; 2018 Oct; 24(4):600-610.e4. PubMed ID: 30308161
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with early outcomes following standardised therapy in children with ulcerative colitis (PROTECT): a multicentre inception cohort study.
Hyams JS; Davis S; Mack DR; Boyle B; Griffiths AM; LeLeiko NS; Sauer CG; Keljo DJ; Markowitz J; Baker SS; Rosh J; Baldassano RN; Patel A; Pfefferkorn M; Otley A; Heyman M; Noe J; Oliva-Hemker M; Rufo P; Strople J; Ziring D; Guthery SL; Sudel B; Benkov K; Wali P; Moulton D; Evans J; Kappelman MD; Marquis A; Sylvester FA; Collins MH; Venkateswaran S; Dubinsky M; Tangpricha V; Spada KL; Britt A; Saul B; Gotman N; Wang J; Serrano J; Kugathasan S; Walters T; Denson LA
Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):855-868. PubMed ID: 28939374
[TBL] [Abstract][Full Text] [Related]
3. Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease.
Shaw KA; Bertha M; Hofmekler T; Chopra P; Vatanen T; Srivatsa A; Prince J; Kumar A; Sauer C; Zwick ME; Satten GA; Kostic AD; Mulle JG; Xavier RJ; Kugathasan S
Genome Med; 2016 Jul; 8(1):75. PubMed ID: 27412252
[TBL] [Abstract][Full Text] [Related]
4. Clinical and biological predictors of response to standardised paediatric colitis therapy (PROTECT): a multicentre inception cohort study.
Hyams JS; Davis Thomas S; Gotman N; Haberman Y; Karns R; Schirmer M; Mo A; Mack DR; Boyle B; Griffiths AM; LeLeiko NS; Sauer CG; Keljo DJ; Markowitz J; Baker SS; Rosh J; Baldassano RN; Patel A; Pfefferkorn M; Otley A; Heyman M; Noe J; Oliva-Hemker M; Rufo PA; Strople J; Ziring D; Guthery SL; Sudel B; Benkov K; Wali P; Moulton D; Evans J; Kappelman MD; Marquis MA; Sylvester FA; Collins MH; Venkateswaran S; Dubinsky M; Tangpricha V; Spada KL; Saul B; Wang J; Serrano J; Hommel K; Marigorta UM; Gibson G; Xavier RJ; Kugathasan S; Walters T; Denson LA
Lancet; 2019 Apr; 393(10182):1708-1720. PubMed ID: 30935734
[TBL] [Abstract][Full Text] [Related]
5. Gut Microbiome Changes in Patients with Active Left-Sided Ulcerative Colitis after Fecal Microbiome Transplantation and Topical 5-aminosalicylic Acid Therapy.
Schierová D; Březina J; Mrázek J; Fliegerová KO; Kvasnová S; Bajer L; Drastich P
Cells; 2020 Oct; 9(10):. PubMed ID: 33066233
[TBL] [Abstract][Full Text] [Related]
6. Evolution and predictive factors of relapse in ulcerative colitis patients treated with mesalazine after a first course of corticosteroids.
Bello C; Belaiche J; Louis E; Reenaers C
J Crohns Colitis; 2011 Jun; 5(3):196-202. PubMed ID: 21575881
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal non-adherence predicts treatment escalation in paediatric ulcerative colitis.
Carmody JK; Plevinsky J; Peugh JL; Denson LA; Hyams JS; Lobato D; LeLeiko NS; Hommel KA
Aliment Pharmacol Ther; 2019 Oct; 50(8):911-918. PubMed ID: 31373712
[TBL] [Abstract][Full Text] [Related]
8. The rectal mucosal but not fecal microbiota detects subclinical ulcerative colitis.
Lin YF; Sung CM; Ke HM; Kuo CJ; Liu WA; Tsai WS; Lin CY; Cheng HT; Lu MJ; Tsai IJ; Hsieh SY
Gut Microbes; 2021; 13(1):1-10. PubMed ID: 33525983
[TBL] [Abstract][Full Text] [Related]
9. Presenting features and disease course of pediatric ulcerative colitis.
Aloi M; D'Arcangelo G; Pofi F; Vassallo F; Rizzo V; Nuti F; Di Nardo G; Pierdomenico M; Viola F; Cucchiara S
J Crohns Colitis; 2013 Dec; 7(11):e509-15. PubMed ID: 23583691
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and Risk Factors for Therapy Escalation in Ulcerative Colitis in the Swiss IBD Cohort Study.
Safroneeva E; Vavricka SR; Fournier N; Straumann A; Rogler G; Schoepfer AM
Inflamm Bowel Dis; 2015 Jun; 21(6):1348-58. PubMed ID: 25806845
[TBL] [Abstract][Full Text] [Related]
11. Determinants of Reduced Genetic Capacity for Butyrate Synthesis by the Gut Microbiome in Crohn's Disease and Ulcerative Colitis.
Laserna-Mendieta EJ; Clooney AG; Carretero-Gomez JF; Moran C; Sheehan D; Nolan JA; Hill C; Gahan CGM; Joyce SA; Shanahan F; Claesson MJ
J Crohns Colitis; 2018 Jan; 12(2):204-216. PubMed ID: 29373727
[TBL] [Abstract][Full Text] [Related]
12. Alterations in the gut microbiome of children with severe ulcerative colitis.
Michail S; Durbin M; Turner D; Griffiths AM; Mack DR; Hyams J; Leleiko N; Kenche H; Stolfi A; Wine E
Inflamm Bowel Dis; 2012 Oct; 18(10):1799-808. PubMed ID: 22170749
[TBL] [Abstract][Full Text] [Related]
13. Early Change in Fecal Calprotectin Predicts One-Year Outcome in Children Newly Diagnosed With Ulcerative Colitis.
Krishnakumar C; Ananthakrishnan AN; Boyle BM; Griffiths AM; LeLeiko NS; Mack DR; Markowitz JF; Rosh JR; Sauer CG; Walters TD; Bonkowski E; Denson LA; Hyams JS; Kugathasan S
J Pediatr Gastroenterol Nutr; 2022 Jan; 74(1):72-78. PubMed ID: 34433783
[TBL] [Abstract][Full Text] [Related]
14. Gut dysbiosis and clinical phases of pancolitis in patients with ulcerative colitis.
Maldonado-Arriaga B; Sandoval-Jiménez S; Rodríguez-Silverio J; Lizeth Alcaráz-Estrada S; Cortés-Espinosa T; Pérez-Cabeza de Vaca R; Licona-Cassani C; Gámez-Valdez JS; Shaw J; Mondragón-Terán P; Hernández-Cortez C; Suárez-Cuenca JA; Castro-Escarpulli G
Microbiologyopen; 2021 Mar; 10(2):e1181. PubMed ID: 33970546
[TBL] [Abstract][Full Text] [Related]
15. Features of the gut microbiota in ulcerative colitis patients with depression: A pilot study.
Chen DL; Dai YC; Zheng L; Chen YL; Zhang YL; Tang ZP
Medicine (Baltimore); 2021 Feb; 100(7):e24845. PubMed ID: 33607855
[TBL] [Abstract][Full Text] [Related]
16. Clinical and Host Biological Factors Predict Colectomy Risk in Children Newly Diagnosed With Ulcerative Colitis.
Hyams JS; Brimacombe M; Haberman Y; Walters T; Gibson G; Mo A; Mack D; Griffiths A; Boyle B; LeLeiko N; Markowitz J; Rosh J; Patel A; Shah S; Baldassano R; Pfefferkorn M; Sauer C; Dailey J; Venkateswaran S; Kugathasan S; Denson LA
Inflamm Bowel Dis; 2022 Feb; 28(2):151-160. PubMed ID: 33904583
[TBL] [Abstract][Full Text] [Related]
17. Specific members of the predominant gut microbiota predict pouchitis following colectomy and IPAA in UC.
Machiels K; Sabino J; Vandermosten L; Joossens M; Arijs I; de Bruyn M; Eeckhaut V; Van Assche G; Ferrante M; Verhaegen J; Van Steen K; Van Immerseel F; Huys G; Verbeke K; Wolthuis A; de Buck Van Overstraeten A; D'Hoore A; Rutgeerts P; Vermeire S
Gut; 2017 Jan; 66(1):79-88. PubMed ID: 26423113
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of ulcerative colitis in patients who achieve clinical remission with a first course of corticosteroids.
Garcia-Planella E; Mañosa M; Van Domselaar M; Gordillo J; Zabana Y; Cabré E; López San Román A; Domènech E
Dig Liver Dis; 2012 Mar; 44(3):206-10. PubMed ID: 22079262
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naïve and non-naïve patients.
Iborra M; Pérez-Gisbert J; Bosca-Watts MM; López-García A; García-Sánchez V; López-Sanromán A; Hinojosa E; Márquez L; García-López S; Chaparro M; Aceituno M; Calafat M; Guardiola J; Belloc B; Ber Y; Bujanda L; Beltrán B; Rodríguez-Gutiérrez C; Barrio J; Cabriada JL; Rivero M; Camargo R; van Domselaar M; Villoria A; Schuterman HS; Hervás D; Nos P;
J Gastroenterol; 2017 Jul; 52(7):788-799. PubMed ID: 27722996
[TBL] [Abstract][Full Text] [Related]
20. Mucosa-associated gut microbiota reflects clinical course of ulcerative colitis.
Nishihara Y; Ogino H; Tanaka M; Ihara E; Fukaura K; Nishioka K; Chinen T; Tanaka Y; Nakayama J; Kang D; Ogawa Y
Sci Rep; 2021 Jul; 11(1):13743. PubMed ID: 34215773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
